Aptuit, a provider of integrated early to mid-phase drug development services, has appointed Paul D. Overton, Ph.D., executive vice president, business development and marketing, making him responsible for all of Aptuit's sales and marketing activities.

Paul Overton successfully led the global sales, marketing and program management team at Huntingdon Life Sciences and grew the business significantly year on year. He was instrumental in developing late stage discovery and translational sciences partnerships for the company. During his tenure he realigned marketing into the sales function and rolled out a content marketing program utilizing social media. Previously, Overton held key leadership positions at Covance Laboratories, LCG Biosciences, Origin Pharmaceutical Services and Cambridge Life Sciences.

Overton, who will be based in the U.K., will report directly to Jonathan Goldman, M.D., Aptuit's CEO, and will be a member of Aptuit's executive committee.